A Good Biomarker Is Hard to Find | GenomeWeb

Are cancer biomarkers all they're cracked up to be? Not always, writes Monica Desai in the Guardian's science blog. Of the thousands of biomarkers researchers are aware of, only a small percentage of them is being used in the clinic to find treatments for disease. There have been successes like HER-2 in breast cancer which led to the formulation of Herceptin, Desai says, but not every biomarker turns out to be as useful.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.